Your Options Request a formulary exception your doctor can argue medical necessity If Zepbound is not covered by your insurance Try the OSA pathway if you have sleep apnea, some plans that exclude weight loss still cover Zepbound for OSA Sleep Apnea Coverage Guide Talk to HR if you have employer insurance, ask if they can add GLP-1 coverage at renewal Switch plans during open enrollment verify GLP-1 coverage in writing before switching Explore self-pay options savings cards, LillyDirect ($299-$449/mo), TrumpRx.gov (~$346/mo, launched Feb 2026), and patient assistance may reduce costs Zepbound Cost Guide Consider oral options Foundayo (Eli Lilly's new oral GLP-1, FDA approved April 1, 2026) may have different coverage OSA Coverage May Be Different Sleep Apnea Indication Worth Exploring Zepbound was FDA-approved to treat obstructive sleep apnea (OSA) in adults with obesity

Canada part of a multi-country global rollout Novo Nordisk's Canadian patent expired in January 2026, and generic semaglutide became legal in India on March 23, 2026
In rare cases, injection site reactions and reaction management may relate to immune responses
Tirzepatide is administered as a subcutaneous injection
For alopecia, a striking pattern emerged: tirzepatide 5 mg led to 5.1 per cent, 10 mg to 5.3 per cent and 15 mg to 4.9 per cent hair loss, against 0.9 per cent on placebo
This multi-layered patent protection is designed to prevent other manufacturers from creating generic versions until the key patents expire